Mode
Text Size
Log in / Sign up

Diabetic neuropathy

Part of Diabetes

Subtypes of Diabetic neuropathy

Diabetic Foot Ulcers 18 Diabetic foot 3

25 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for diabetic neuropathy

16 trials tracked for diabetic neuropathy: 8 in phase 3 or 4.

16Trials tracked
8Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 4 Phase 3 4 Phase 2 5 Phase 1 1 Other / NA 2
  1. Phase 4 Lovaza® and Microvascular Function in Type 2 Diabetes Completed
  2. Phase 4 Alpha Lipoic Acid for Treatment of Diabetic Neuropathy Completed
  3. Phase 4 A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy Completed
  4. Phase 4 A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy Completed
  5. Phase 3 An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed
  6. Phase 3 A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy Completed
Show 10 more trials
  1. Phase 3 A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy Completed
  2. Phase 3 A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy Completed
  3. Phase 2 The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy Completed
  4. Phase 2 A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN) Completed
  5. Phase 2 Study of DA-9801 to Treat Diabetic Neuropathy Completed
  6. Phase 2 Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy Completed
  7. Phase 2 Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy Completed
  8. Phase 1 Neuropathic Pain Syndrome Patient Study (MK-0000-072) Completed
  9. N/A Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy Completed
  10. N/A Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Diabetes

Related studies from across the Diabetes family.

Euonymus alatus may improve glucose metabolism and reduce urinary protein in diabetic nephropathy
Diabetes & Endocrinology Sys. Review
Euonymus alatus may improve glucose metabolism and reduce urinary protein in diabetic nephropathy Plant extract shows promise in managing diabetes and kidney health
This systematic review of preclinical and clinical data indicates that Euonymus alatus may lower blood glucose, reduce urinary protein, and …
A review of the plant Euonymus alatus suggests it may lower blood sugar and protect kidneys in people with diabetes.
Pharmacist-led medication therapy management improves adherence and glycemic control in a patient with complex T2DM
Rheumatology Sys. Review
Pharmacist-led medication therapy management improves adherence and glycemic control in a patient with complex T2DM Pharmacist-led care improves blood sugar for woman with long-term diabetes
This case report describes a single patient with type 2 diabetes who received pharmacist-led medication therapy management. The intervention…
A pharmacist-led review helped a woman with a 30-year history of Type 2 Diabetes significantly improve her medication adherence and blood su…
Intravenous alpha-lipoic acid optimizes symptom relief while oral administration supports structural repair in DPN
Neurology Meta-analysis
Intravenous alpha-lipoic acid optimizes symptom relief while oral administration supports structural repair in DPN Different ways to give alpha-lipoic acid help diabetic nerve pain
This Bayesian network meta-analysis evaluates various alpha-lipoic acid (ALA) administration routes for diabetic peripheral neuropathy. Find…
New data shows that intravenous and oral versions of alpha-lipoic acid offer different benefits for managing symptoms and repairing nerves i…
Microvascular alteration is a statistically significant determinant for diabetic peripheral neuropathy prevalence
Neurology Meta-analysis
Microvascular alteration is a statistically significant determinant for diabetic peripheral neuropathy prevalence New data reveals key drivers of nerve damage in diabetes
This meta-analysis of 83,560 patients across 24 countries identified a global diabetic peripheral neuropathy (DPN) prevalence of 57.42% (95%…
Over half of people with diabetes suffer from nerve damage, but new data highlights specific blood vessel changes as a primary driver of the…
Nerve decompressive surgery of the lower limbs reduces pain scores in patients with diabetic peripheral neuropathy
Anesthesiology & Pain Medicine Meta-analysis
Nerve decompressive surgery of the lower limbs reduces pain scores in patients with diabetic peripheral neuropathy Nerve surgery may reduce pain for patients with diabetic neuropathy
This meta-analysis of 7 trials involving 207 patients found that nerve decompressive surgery of the lower limbs (NDSLL) significantly reduce…
New analysis shows nerve decompression surgery can lower pain scores for some people with diabetic peripheral neuropathy.
AI-OCT reports reduced false-positive DME referral rates from 69.1% to 24.1%
Diabetes & Endocrinology RCT
AI-OCT reports reduced false-positive DME referral rates from 69.1% to 24.1% AI technology reduces unnecessary referrals for diabetic macular edema
This randomized clinical trial evaluated the impact of AI-OCT reports on identifying diabetic macular edema (DME) in patients with diabetes.…
New research shows that adding AI-powered imaging can significantly cut down on false alarms when screening patients for eye issues caused b…
Vitamin D supplementation shows low certainty reductions in urinary markers for diabetic kidney disease
Nephrology Meta-analysis
Vitamin D supplementation shows low certainty reductions in urinary markers for diabetic kidney disease Vitamin D shows limited benefit for diabetic kidney disease
This umbrella review meta-analysis evaluates vitamin D and its analogs in patients with diabetic kidney disease. While some reduction in uri…
Vitamin D may lower protein in urine for diabetic kidney disease, but evidence is weak and no benefit for kidney function or survival.
Balanced crystalloids reduce time to DKA resolution by 1.60 hours compared to 0.9% saline
Pediatrics Meta-analysis
Balanced crystalloids reduce time to DKA resolution by 1.60 hours compared to 0.9% saline Balanced Crystalloids May Speed Recovery in Pediatric Diabetic Ketoacidosis
This meta-analysis of 320 pediatric patients with diabetic ketoacidosis found that balanced crystalloids significantly reduced the time to D…
A review of data suggests balanced crystalloid fluids may resolve diabetic ketoacidosis faster than standard saline in children.
Early subcutaneous basal insulin plus IV insulin reduces time to DKA resolution by 4.06 hours
Diabetes & Endocrinology Meta-analysis
Early subcutaneous basal insulin plus IV insulin reduces time to DKA resolution by 4.06 hours Early Subcutaneous Insulin Shortens Recovery Time for Diabetic Ketoacidosis
This meta-analysis of randomized controlled trials evaluated adding early subcutaneous basal insulin to intravenous insulin for adults with …
Adding early subcutaneous insulin to IV treatment can speed up recovery for patients with diabetic ketoacidosis without increasing safety ri…
Fluocinolone Acetonide Implant Shows Reduced Injection Frequency for Diabetic Macular Edema
Ophthalmology RCT
Fluocinolone Acetonide Implant Shows Reduced Injection Frequency for Diabetic Macular Edema Fluocinolone Acetonide Implant May Reduce Injection Frequency for DME
A Phase 4 trial shows fluocinolone acetonide implants achieve similar visual outcomes to aflibercept with significantly fewer total injectio…
A new eye implant for diabetic macular edema may significantly reduce the number of monthly injections needed to maintain vision.
miR-29a-3p and miR-204-5p are downregulated in diabetic nephropathy as potential biomarker candidates
Ophthalmology Meta-analysis
miR-29a-3p and miR-204-5p are downregulated in diabetic nephropathy as potential biomarker candidates Specific MicroRNA Signatures Linked to Type 1 Diabetes Complications
This systematic review and meta-analysis of 9 studies involving 34 contrasts identified specific circulating miRNA signatures associated wit…
Researchers identified specific microRNA signals that may help track kidney and eye damage in patients with Type 1 Diabetes.
Immunometabolic dysregulation drives hyperalgesia and hypoesthesia in diabetic peripheral neuropathy
Neurology Sys. Review
Immunometabolic dysregulation drives hyperalgesia and hypoesthesia in diabetic peripheral neuropathy New research explores how inflammation drives nerve damage in diabetes
This narrative review explores the pathophysiology of diabetic peripheral neuropathy, focusing on how hyperglycemia, lipotoxicity, and intes…
Chronic high blood sugar causes more than just high glucose; it triggers a cycle of inflammation and immune stress that damages nerves.

All diabetic neuropathy Articles